Logo image
Clostridium difficile laboratory testing in Australia and New Zealand: national survey results and Australasian Society for Infectious Diseases recommendations for best practice
Journal article   Peer reviewed

Clostridium difficile laboratory testing in Australia and New Zealand: national survey results and Australasian Society for Infectious Diseases recommendations for best practice

J.K. Ferguson, A.C. Cheng, G. L. Gilbert, T. Gottlieb, T. Korman, A. Mcgregor, M. Richards, S. Roberts, J. Robson, H.V. Gessel, …
Pathology, Vol.43(5), pp.482-487
2011
url
Link to Published Version *Subscription may be requiredView

Abstract

Aims: In order to improve the future reliability of surveillance for Clostridium difficile infection (CDI), an Australia/New Zealand-wide survey was conducted to examine methods of laboratory diagnosis in use, identify deficiencies in practice and burden of CDI. Methods: An online survey of 48 Australian and New Zealand microbiology laboratories (private and public) was conducted in late 2009 and 2010 to collect information about methods of detection in use and collective testing experience from July 2008 to June 2009. Results: The overall prevalence (proportion positive of all faecal specimens tested) of C. difficile in 123 574 tested samples was 5.3%. The incidence rate across jurisdictions varied between 18.0 per 100 000 population in Victoria to 35.8 per 100 000 population in Tasmania, with a mean for Australia of 25.6 per 100 000 population. The incidence rate in New Zealand was 21.5 per 100 000 population. Most laboratories (60%) screened stools with an enzyme immunoassay (EIA) or equivalent that detected both toxins A and B. Conclusions: The low overall rates reported here may reflect the lack of sensitivity of diagnostic testing procedures currently used inAustralia andNewZealand to detect C. difficile.Recommendations for best practice in diagnosis of C. difficile were developed by the Australasian Society for Infectious Diseases (ASID) C. difficile working party and later endorsed by ASID.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.120 Inflammatory Bowel Diseases & Infections
1.120.1133 Clostridium Infections
Web Of Science research areas
Pathology
ESI research areas
Clinical Medicine
Logo image